These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11029600)

  • 1. LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion.
    Stenvinkel P; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 2000 Oct; 30(10):866-70. PubMed ID: 11029600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopheresis in the nephrotic syndrome.
    Brunton C; Varghese Z; Moorhead JF
    Kidney Int Suppl; 1999 Jul; 71():S6-9. PubMed ID: 10412726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome.
    Stenvinkel P; Berglund L; Ericsson S; Alvestrand A; Angelin B; Eriksson M
    Eur J Clin Invest; 1997 Feb; 27(2):169-77. PubMed ID: 9061312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
    Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
    Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
    de Zeeuw D; Gansevoort RT; Dullaart RP; de Jong PE
    J Hypertens Suppl; 1995 Jul; 13(1):S53-8. PubMed ID: 18800457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome.
    Noto D; Barbagallo CM; Cascio AL; Cefalù AB; Cavera G; Caldarella R; Marino G; Travali S; Cutaia I; Maringhini S; Notarbartolo A; Averna M
    Kidney Int; 1999 Jun; 55(6):2433-9. PubMed ID: 10354292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
    Berg AL; Nilsson-Ehle P; Arnadottir M
    Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
    Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL-apheresis significantly reduces urinary apo(a) excretion.
    Kostner KM; Jansen M; Maurer G; Derfler K
    Eur J Clin Invest; 1997 Jan; 27(1):93-5. PubMed ID: 9041383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.
    Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D
    J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
    Muso E; Mune M; Hirano T; Hattori M; Kimura K; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Yuzawa Y; Takemura T; Sugiyama S; Nishizawa Y; Ogahara S; Yorioka N; Sakai S; Ogura Y; Yukawa S; Iino Y; Imai E; Matsuo S; Saito T
    Clin Exp Nephrol; 2015 Jun; 19(3):379-86. PubMed ID: 24934117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and urine leptin concentration in children with nephrotic syndrome.
    Wasilewska A; Tomaszewska B; Zoch-Zwierz W; Biernacka A; Klewinowska K; Koput A
    Pediatr Nephrol; 2005 May; 20(5):597-602. PubMed ID: 15782310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy?
    Kronenberg F; Lingenhel A; Lhotta K; Rantner B; Kronenberg MF; König P; Thiery J; Koch M; von Eckardstein A; Dieplinger H
    Kidney Int; 2004 Jul; 66(1):348-54. PubMed ID: 15200443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism.
    Black IW; Wilcken DE
    Clin Chem; 1992 Mar; 38(3):353-7. PubMed ID: 1547551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication.
    Yang X; Wang H; Zhu Z; Deng A
    J Tongji Med Univ; 1998; 18(4):236-8. PubMed ID: 10806854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia and nephrotic syndrome: recent advances.
    Kronenberg F
    J Ren Nutr; 2005 Apr; 15(2):195-203. PubMed ID: 15827892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.